We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Healthcare | 14.21% |
| 3 | Technology | 14.12% |
| 4 | Consumer Staples | 9.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLOW
801
DELISTED
SPX FLOW, Inc.
FLOW
| $2.02M | 0.02% |
77,427
+5,605
| +8% | +$159K |
|
802
Ashland
ASH
$3.32B
| $2.02M | 0.02% |
35,954
+1,758
| +5% | +$97.3K |
|
|
FLG
803
Flagstar Bank National Association
FLG
$5.95B
| $2.01M | 0.02% |
44,675
-11,021
| -20% | -$502K |
|
804
AGCO
AGCO
$7.46B
| $2.01M | 0.02% |
42,591
-1,840
| -4% | -$94.5K |
|
|
PRMW
805
DELISTED
Primo Water Corporation
PRMW
| $2.01M | 0.02% |
143,750
+1,000
| +0.7% | +$14.4K |
|
806
America Movil
AMX
$76.3B
| $2M | 0.02% |
163,436
-110,912
| -40% | -$1.48M |
|
807
West Pharmaceutical
WST
$24B
| $2M | 0.02% |
26,404
+896
| +4% | +$65.2K |
|
808
NXP Semiconductors
NXPI
$59.7B
| $2M | 0.02% |
25,564
+2,515
| +11% | +$216K |
|
|
ISIL
809
DELISTED
Intersil Corp
ISIL
| $1.99M | 0.02% |
147,279
+122,634
| +498% | +$1.59M |
|
810
Cheniere Energy
LNG
$55B
| $1.99M | 0.02% |
53,002
-8,020
| -13% | -$282K |
|
811
Palo Alto Networks
PANW
$269B
| $1.99M | 0.02% |
97,230
+6,948
| +8% | +$161K |
|
812
ServiceNow
NOW
$115B
| $1.98M | 0.02% |
148,850
+33,490
| +29% | +$465K |
|
813
Acuity Brands
AYI
$10B
| $1.97M | 0.02% |
7,937
+1,285
| +19% | +$321K |
|
|
ITCL
814
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
| $1.97M | 0.02% |
+154,007
| New | +$1.95M |
|
815
Enovis
ENOV
$1.66B
| $1.96M | 0.02% |
43,057
+735
| +2% | +$35.9K |
|
816
Spire
SR
$4.75B
| $1.95M | 0.02% |
27,546
+481
| +2% | +$31.6K |
|
817
Graco
GGG
$12.9B
| $1.94M | 0.02% |
73,551
+40,833
| +125% | +$1.1M |
|
818
Bio-Rad Laboratories Class A
BIO
$8.67B
| $1.94M | 0.02% |
13,530
+4,901
| +57% | +$699K |
|
819
Sibanye-Stillwater
SBSW
$6.23B
| $1.93M | 0.02% |
150,060
-3,933
| -3% | -$50.1K |
|
820
Revvity
RVTY
$12.6B
| $1.92M | 0.02% |
36,713
-798
| -2% | -$42K |
|
|
HBI
821
DELISTED
Hanesbrands
HBI
| $1.92M | 0.02% |
76,432
-6,474
| -8% | -$176K |
|
|
NE
822
DELISTED
Noble Corporation
NE
| $1.92M | 0.02% |
232,957
-2,608
| -1% | -$24.9K |
|
823
Cooper Companies
COO
$14B
| $1.92M | 0.02% |
44,640
+8,276
| +23% | +$331K |
|
824
American Airlines Group
AAL
$10.1B
| $1.91M | 0.01% |
67,547
-47,260
| -41% | -$1.6M |
|
825
Charles River Laboratories
CRL
$11.2B
| $1.91M | 0.01% |
23,188
+5,055
| +28% | +$416K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.